OME Health provides a personalised 12-week health plans based on a person’s gut microbiome, genetics, blood markers, and other health data. Inventure led the round, which also gained participation from Doehler Group, Practica Capital, and a group of angel investors in the UK.
OME Health was founded in 2016. After closing its seed funding, the company started to focus its efforts on its commercial activities in the UK and Europe. OME Health currently partners with Bupa and food manufacturers to offer personalised nutrition plans and health recommendations.